FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556827669> ?p ?o ?g. }

• W2556827669 endingPage "2602" @default.
• W2556827669 startingPage "2602" @default.
• W2556827669 abstract "The Sustainable Development Goal 3 presented by the UN1UNSustainable development goals. Ban establishes eminent panel to help broaden access to quality medicines at affordable costs. UN. Nov 25, 2015.http://www.un.org/sustain abledevelopment/blog/2015/11/ban-establish%20es-eminent-panel-to-help-broaden-access-to-quality-medicines-at-affordable-costs/Google Scholar emphasises that there is an urgent need to ensure that everyone has access to quality treatment at affordable costs. Therefore, among several interventions, one method to control health-care costs is to make sure that medicines are reasonably priced and affordable to the general population. However, affordability of medicines seems to be of low importance to policy makers in Pakistan. In recent months, prices of hundreds of essential and life-saving medicines have increased greatly in Pakistan, making them unaffordable to residents with low and middle incomes. For some of these medicines, a price increase of over 100% has been observed. For example, the price of the frequently prescribed antispasmodic drotaverine has increased by 218%, while that of commonly used cough syrup dextromethorphan hydrobromide, chlorpheniramine, and pseudoephedrine increased by 105%. Additionally, the price of an injection of vitamins B1, B6, and B12 increased by 85%.2Chaudhry A Authorities fail to check steep drug price hike. Dawn. Aug 22, 2016.http://www.dawn.com/news/1279112Google Scholar Numerous medicines have recently increased in price over 2–3 months, making them unaffordable for patients. The situation is getting out of hand for the people of Pakistan because there is no national health insurance, and most of the health-associated expenditure is an out-of-pocket expense. A major reason for this uncontrollable price hike is the unsatisfactory performance of the Drug Regulatory Authority of Pakistan (DRAP) and other associated agencies. Medicine prices in Pakistan were officially permitted by DRAP to increase four times between June and August, 2016; however, pharmaceutical companies ignored DRAP's notification and instead raised the prices five times over the 3 months. Shockingly, this illegitimate increase in price was not acknowledged or acted upon by DRAP in Pakistan. Despite the fact that the Ministry of National Health Services, Regulations, and Coordination (NHSRC) admitted that the medicines of some multinational companies were overpriced, no action was taken. Notably, the issue of the price increases was highlighted at the federal parliament of Pakistan in February, 2016, whereby the parliamentarians instructed NHSRC and DRAP to take strict action against pharmaceutical companies who were plundering the masses by increasing prices of medicines unilaterally. Furthermore, a subsidy of medicines that had increased in price was proposed. The price hike was strongly condemned and the Senate's Standing Committee on National Health Services, Regulations and Coordination instructed that no second chances should be given to these companies.3The Express TribunePrice hike: legislators call for action against pharma companies.http://tribune.com.pk/story/1050702/price-hike-legislators-call-for-action-against-pharma-companies/Date: Feb 20, 2016Google Scholar However, no action was taken and patients were left at the mercy of the pharmaceutical companies, so they had no choice but to pay exorbitant prices for medicines that were affordable just a few months before. Within this context, surely pharmaceutical companies in Pakistan are using various tactics to avoid scrutiny from the regulatory authorities. At the same time, the leniency of the regulatory authorities is also evident. It is time for health authorities in Pakistan to start learning from past experiences. An amendment in the relevant schedule appended to the Drug and Pricing Act is needed that will allow the government to place stern policies on price control, and actions to be taken in case of illegitimate price hikes. Instead of listening to the demands of the pharmaceutical industry, the Pakistani Government should start listening to the people, who are now faced with unaffordable medicines. We declare no competing interests. Essential medicines for universal health coverageEssential medicines satisfy the priority health-care needs of the population. Essential medicines policies are crucial to promoting health and achieving sustainable development. Sustainable Development Goal 3.8 specifically mentions the importance of “access to safe, effective, quality and affordable essential medicines and vaccines for all” as a central component of Universal Health Coverage (UHC), and Sustainable Development Goal 3.b emphasises the need to develop medicines to address persistent treatment gaps. Full-Text PDF" @default.
• W2556827669 created "2016-11-30" @default.
• W2556827669 creator A5018285176 @default.
• W2556827669 creator A5050455291 @default.
• W2556827669 creator A5055241903 @default.
• W2556827669 creator A5070959033 @default.
• W2556827669 creator A5080734914 @default.
• W2556827669 date "2016-11-01" @default.
• W2556827669 modified "2023-09-27" @default.
• W2556827669 title "Uncontrollable medicine prices in Pakistan" @default.
• W2556827669 doi "https://doi.org/10.1016/s0140-6736(16)32120-1" @default.
• W2556827669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27832869" @default.
• W2556827669 hasPublicationYear "2016" @default.
• W2556827669 type Work @default.
• W2556827669 sameAs 2556827669 @default.
• W2556827669 citedByCount "10" @default.
• W2556827669 countsByYear W25568276692017 @default.
• W2556827669 countsByYear W25568276692019 @default.
• W2556827669 countsByYear W25568276692020 @default.
• W2556827669 countsByYear W25568276692021 @default.
• W2556827669 countsByYear W25568276692022 @default.
• W2556827669 crossrefType "journal-article" @default.
• W2556827669 hasAuthorship W2556827669A5018285176 @default.
• W2556827669 hasAuthorship W2556827669A5050455291 @default.
• W2556827669 hasAuthorship W2556827669A5055241903 @default.
• W2556827669 hasAuthorship W2556827669A5070959033 @default.
• W2556827669 hasAuthorship W2556827669A5080734914 @default.
• W2556827669 hasBestOaLocation W25568276691 @default.
• W2556827669 hasConcept C100406419 @default.
• W2556827669 hasConcept C111472728 @default.
• W2556827669 hasConcept C118552586 @default.
• W2556827669 hasConcept C138885662 @default.
• W2556827669 hasConcept C144133560 @default.
• W2556827669 hasConcept C160735492 @default.
• W2556827669 hasConcept C162324750 @default.
• W2556827669 hasConcept C17744445 @default.
• W2556827669 hasConcept C199539241 @default.
• W2556827669 hasConcept C27415008 @default.
• W2556827669 hasConcept C2777424817 @default.
• W2556827669 hasConcept C2779356469 @default.
• W2556827669 hasConcept C2779530757 @default.
• W2556827669 hasConcept C2908647359 @default.
• W2556827669 hasConcept C2909665878 @default.
• W2556827669 hasConcept C3019492093 @default.
• W2556827669 hasConcept C50522688 @default.
• W2556827669 hasConcept C512399662 @default.
• W2556827669 hasConcept C71924100 @default.
• W2556827669 hasConcept C83864248 @default.
• W2556827669 hasConcept C99454951 @default.
• W2556827669 hasConceptScore W2556827669C100406419 @default.
• W2556827669 hasConceptScore W2556827669C111472728 @default.
• W2556827669 hasConceptScore W2556827669C118552586 @default.
• W2556827669 hasConceptScore W2556827669C138885662 @default.
• W2556827669 hasConceptScore W2556827669C144133560 @default.
• W2556827669 hasConceptScore W2556827669C160735492 @default.
• W2556827669 hasConceptScore W2556827669C162324750 @default.
• W2556827669 hasConceptScore W2556827669C17744445 @default.
• W2556827669 hasConceptScore W2556827669C199539241 @default.
• W2556827669 hasConceptScore W2556827669C27415008 @default.
• W2556827669 hasConceptScore W2556827669C2777424817 @default.
• W2556827669 hasConceptScore W2556827669C2779356469 @default.
• W2556827669 hasConceptScore W2556827669C2779530757 @default.
• W2556827669 hasConceptScore W2556827669C2908647359 @default.
• W2556827669 hasConceptScore W2556827669C2909665878 @default.
• W2556827669 hasConceptScore W2556827669C3019492093 @default.
• W2556827669 hasConceptScore W2556827669C50522688 @default.
• W2556827669 hasConceptScore W2556827669C512399662 @default.
• W2556827669 hasConceptScore W2556827669C71924100 @default.
• W2556827669 hasConceptScore W2556827669C83864248 @default.
• W2556827669 hasConceptScore W2556827669C99454951 @default.
• W2556827669 hasIssue "10060" @default.
• W2556827669 hasLocation W25568276691 @default.
• W2556827669 hasLocation W25568276692 @default.
• W2556827669 hasOpenAccess W2556827669 @default.
• W2556827669 hasPrimaryLocation W25568276691 @default.
• W2556827669 hasRelatedWork W1528949 @default.
• W2556827669 hasRelatedWork W2556827669 @default.
• W2556827669 hasRelatedWork W2600284691 @default.
• W2556827669 hasRelatedWork W2613705809 @default.
• W2556827669 hasRelatedWork W2734624616 @default.
• W2556827669 hasRelatedWork W3014476556 @default.
• W2556827669 hasRelatedWork W4282937375 @default.
• W2556827669 hasRelatedWork W4311079528 @default.
• W2556827669 hasRelatedWork W44955007 @default.
• W2556827669 hasRelatedWork W84378478 @default.
• W2556827669 hasVolume "388" @default.
• W2556827669 isParatext "false" @default.
• W2556827669 isRetracted "false" @default.
• W2556827669 magId "2556827669" @default.
• W2556827669 workType "article" @default.